Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AQF

CRYSTAL STRUCTURE OF HUMAN MONOGLYCERIDE LIPASE WITH COMPOUND LEI-515

8AQF の概要
エントリーDOI10.2210/pdb8aqf/pdb
分子名称Monoglyceride lipase, 1-[(~{R})-[2-chloranyl-4-[(2~{S},3~{S})-4-(3-chlorophenyl)-2,3-dimethyl-piperazin-1-yl]carbonyl-phenyl]sulfinyl]-3,3-bis(fluoranyl)pentan-2-one (3 entities in total)
機能のキーワードmonoacylglycerol lipase, magl, inhibitor, hydrolase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計35996.96
構造登録者
主引用文献Jiang, M.,Huizenga, M.C.W.,Wirt, J.L.,Paloczi, J.,Amedi, A.,van den Berg, R.J.B.H.N.,Benz, J.,Collin, L.,Deng, H.,Di, X.,Driever, W.F.,Florea, B.I.,Grether, U.,Janssen, A.P.A.,Hankemeier, T.,Heitman, L.H.,Lam, T.W.,Mohr, F.,Pavlovic, A.,Ruf, I.,van den Hurk, H.,Stevens, A.F.,van der Vliet, D.,van der Wel, T.,Wittwer, M.B.,van Boeckel, C.A.A.,Pacher, P.,Hohmann, A.G.,van der Stelt, M.
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence.
Nat Commun, 14:8039-8039, 2023
Cited by
PubMed Abstract: Monoacylglycerol lipase (MAGL) regulates endocannabinoid 2-arachidonoylglycerol (2-AG) and eicosanoid signalling. MAGL inhibition provides therapeutic opportunities but clinical potential is limited by central nervous system (CNS)-mediated side effects. Here, we report the discovery of LEI-515, a peripherally restricted, reversible MAGL inhibitor, using high throughput screening and a medicinal chemistry programme. LEI-515 increased 2-AG levels in peripheral organs, but not mouse brain. LEI-515 attenuated liver necrosis, oxidative stress and inflammation in a CCl-induced acute liver injury model. LEI-515 suppressed chemotherapy-induced neuropathic nociception in mice without inducing cardinal signs of CB activation. Antinociceptive efficacy of LEI-515 was blocked by CB, but not CB, antagonists. The CB antagonist rimonabant precipitated signs of physical dependence in mice treated chronically with a global MAGL inhibitor (JZL184), and an orthosteric cannabinoid agonist (WIN55,212-2), but not with LEI-515. Our data support targeting peripheral MAGL as a promising therapeutic strategy for developing safe and effective anti-inflammatory and analgesic agents.
PubMed: 38052772
DOI: 10.1038/s41467-023-43606-3
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.55 Å)
構造検証レポート
Validation report summary of 8aqf
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon